Background: 1-Assess the correlation between Anti-cyclic citralliuated peptide (anti-CCP2) antibodies concentration with some clinical and laboratory parameters of rheumatoid arthritis (RA): 2-Evaluate the differences in the clinical and serological parameters between anti-CCP 2+ve and anti-CCP 2-ve patients and Rheumatoid factor (RF +ve and RF -ve
heumatoid arthritis (RA) is the most common inflammatory joint disease with prevalence between 0.5 and 1% worldwide 1 . The precise etiology of RA is unknown but it has been suggested to be an interaction between genetic and environmental factors 2 . The diagnosis of RA is mainly based on clinical signs and symptoms according to latest recommendations of the American College
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of Rheumatology (ACR) in 1987 3 . Within the seven ACR classification criteria, detection of IgM (RF) in serum is the only recommended laboratory marker. Though IgM-RF is measured in most studies and is the most often ordered autoantibody test in laboratory diagnosis, its specificity for diagnosing RA is limited; at very low levels, IgM-RF is present in sera of most people High concentrations of IgM-RF are not only detected in RA but also in other conditions with polyclonal stimulation to B-cells like viral and bacterial infections or chronic inflammations other than RA 4 . The need for a better laboratory marker with a higher disease-related specificity and sensitivity was always evident. Therefore, a new approach for classification of RA was introduced in 2010by the ACR and the European League against Rheumatism 5 . In the "new "criteria, serology and autoimmune diagnostics carry a major weight, as detection of cyclic citrullinated peptide is appropriate to diagnose the disease in an early state, before joints destructions occur 6 . An additional connection between smoking and anticitrulline auto-antibodies provides further potential insight into mechanisms of disease evolution 7 . Cyclic citrullinated peptide (CCP) IgG antibodies have been described as highly specific for RA 8 .
Rheumatoid factors and anti-CCP antibodies have been shown to be useful diagnostic tools particularly in the early stages of the disease and predictive of disease progression 9 . Moreover, an anti-CCP antibody appears to be a good prognostic marker that helps in discriminating between erosive and nonerosive disease 10 . The disease activity score 28 (DAS28) is used to assess the disease course and treatment outcome and is based on a count of 28specified joints for swelling and tenderness, ESR or Creactive protein (CRP) which are the disease activity markers 11 . Disease activity score28 (DAS28-ESR) was calculated using online calculator by entering the data of tender joint count, swollen joint count of 28 specified joints and ESR for each patient. DAS28 score of higher than 5.1 is indicative of high disease activity, below 3.2 indicates low disease activity and lower than 2.6 is considered remission 11 .
MATERIAL AND METHODS
All data were expressed as a mean ±SD using standard statistical methods. Table 1 , showed significant differences between anti-CCP2 seropositive andanti-CCP2 seronegative groups concerning the age, male gender percentage, smoking history and family history (p=0.000, 0.03, 0.02, 0.03 respectively), however; no significant difference was found in the female gender percentage between the two groups (p=0.45). The laboratory tests including ESR and CRP in anti-CCP2 seropositive and anti-CCP2 seronegative groups showed no significant difference (p=0.240, 0.39 respectively), though; high significant differences were found in RF-latex and RF-ELISA both in positivity and concentration in the two groups of anti-CCP2 status (p=0.01, 0.000 for RF-latex and 0.012, 0.000 for RF-ELISA respectively). groups: Significant differences were noticed between positive and negative patients for anti-CCP2 antibodies and RF-ELISA regarding DAS28 and smoking history (p<0.05). However, RF positive patients differ significantly from RF negative patients in regard to CRP concentration and ESR (p=0.008, 0.05respectively) while no such differences were noted in the two anti-CCP2 status as presented in Table 2 . Moreover, this study showed that 10/55 (18.18%) of the patients had positive smoking history and 8 patients out of them (80%) were anti-CCP2 seropositive, with a significant difference between the positive and negative anti-CCP2 groups (p= 0.02).
The concentration mean of anti-CCP2 antibodies was higher in smokers than non-smokers (259.7 U/ml vs. 162.45 U/ml respectively, p=0.01). For RF, 6 out of 10 smokers were RF positive with a significant difference between positive and negative RF groups (60% vs. 40%; p=0.04), Table 8 . The mean RF concentration in smoker was higher than for non-smoker (443.03 U/ml vs. 289.29 U/ml respectively, p=0.03). The correlation between DAS28 and other laboratory parameters There was a significant correlation between DAS28 and the acute phase reactants (ESR and CRP) with a p-value of 0.000 and 0.03 respectively.
There was also a significant correlation between DAS28 and RF-ELISA and RFlatex (p=0.001, 0.005 respectively), no significant correlation was found betweenDAS28 and Anti-CCP (p=0.16) ( Rheumatoid factor positivity and level were significantly different between anti-CCP2 seropositive and anti-CCP2 seronegative groups by the two methods of detection used in the current study. This result is in accordance with many other studies 15 . In other studies of sera obtained before onset ofRA 25 , anticitrulline antibodies were observed prior to the occurrence of RFsuggesting that the increase in RF titers might, in some of these cases, be an event secondary to anticitrulline impunity and immune complex formation involving citrullinated antigens 28 .
Concerning demographical data; age and disease duration were significantly higher in anti-CCP2 positive than anti-CCP2 negative groups. Ronnelid et al 27 , found that 3.9% of RA patients changed their anti-CCP status from negative to positive with time. This might suggest that, with advanced age or progression of disease onset, anti-CCP status become more frequently seropositive and this might explain why anti-CCP positive group had higher age comparing with negative one. The present study showed that 13 out of 55 RA patients had positive family history for RA; nine out of these 13 (69.2%) were anti-CCP2 positive and 4/13 (30.76%) were anti-CCP2 negative which revealed a significant difference between the two groups. This result matches with the fact that anti-CCP antibodies were associated with HLA-DRB1 SE as a genetic risk factor for RA development 29 .
In general, by comparing the data concerning age, disease duration, ESR, CRP, DAS28 and smoking history obtained in the present study for the positive and negative status between anti-CCP and RF antibodies, the results showed that almost all the differences between anti-CCP2 positive and anti-CCP2 negative groups were fairly comparable to those between RF positive and RF negative groups with the exception that ESR and CRP (inflammatory markers) were significantly different between RF positive and RF negative groups but there was no significant difference between anti-CCP positive and anti-CCP negative groups, again, for ESR and CRP. These results might suggest that the presence of RF is inflammation driven, whereas, the appearance of anti-CCP antibodies suggests patho-physiological properties and a possible contribution to on-going immune activation 20 .
The frequency of RA patients involved in this study who were smokers or exsmokers was 18.18%. The frequency of smokers in anti-CCP2 positive group was found to be significantly higher than in anti-CCP2 negative group (80% vs. 20% respectively). This is in accordance with some studies that imply a strong association between smoking and anti-CCP antibodies formation 30 . In addition, the present study showed that the mean anti-CCP2 antibodies titer was higher for smokers than non-smokers (259.7U/ml vs. 162.45U/ml respectively). However, the presence of high anti-CCP2 titer among members of the current non-smokers group might indicate that other environmental factors contribute to anti-CCP formation 31 .
Regarding RF, a higher frequency of RF-ELISA positive patients was found in the smoker group than non-smoker (60% vs. 40% respectively) comparably with the findings of other investigators 32 . The mean RF level in smokers, like anti-CCP2, was higher than non-smokers (443.025U/ml vs. 289.29U/ml respectively). This is in accordance with the study of Padyukov et al 33 .
In this study, almost all patients were active with a significant association of DAS28 with inflammatory markers (ESR and CRP). These results correlate with previous findings 15,34 . However, DAS28
was not found to be correlated significantly with anti-CCP2 antibodies 15 .
In contrast, Onder et at 35 stated that higher DAS28 scores associated with anti-CCP positivity as discussed earlier in this study. DAS28 scores also found to be correlated significantly with RF-latex and RF-ELISA titers. Serdaroglue et al 15 found a significant correlation between DAS28 and RF. Nevertheless, serum RF measurements have not been useful evaluative tests in RA because changes in titers generally occur slowly and often lag behind other markers of RA activity 36 .
This study has got its own limitations, the studied sample was relatively small, and the results of this study will be more precise if other city hospitals in Iraq were involved. Studies are required to identify patients at early stage of disease before clinical symptoms become apparent. Furthermore, the effects of therapy on anti-CCP antibodies status and/or concentration are required to determine the possibility of using anti-CCP antibodies as a monitor of therapy. 
